Publications
- Plasma levels of soluble endoglin have prognostic significance in patients with chronic lymphocytic leukemia +12008 | Faculty of Medicine in Hradec Králové
- Plasma soluble endoglin ( CD105) concentrations in patients with lymphoid malignancies - a pilot study +1Publication without faculty affiliation
- Plasma soluble endoglin (sCD105) concentrations in patients with lymphoid malignancies: a pilot studyPublication without faculty affiliation
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders2019 | Faculty of Medicine in Hradec Králové
- Treatment of elderly and comorbid patients with chronic lymphocytic leukemia2017 | Faculty of Medicine in Hradec Králové
- Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies2017 | Faculty of Medicine in Hradec Králové
- Primary testicular lymphoma2017 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Venous thromboembolism in patients with chronic lymphocytic leukemia2015 | Faculty of Medicine in Hradec Králové
Loading network view...